Hong Kong IVF clinic ordered to suspend most services after embryo specimen errors

07 luglio 2026

Riportato dall'IA

Hong Kong’s regulator for in vitro fertilisation ordered HEAL Fertility to partially halt operations after it mishandled embryo biopsy specimens from two patients.

The Council on Human Reproductive Technology announced the suspension on Tuesday. It acted after a genetic testing laboratory at Prince of Wales Hospital found that embryo biopsy specimens sent by the clinic belonged to the wrong parents.

Tests took place in May. The council learned of the incident on June 17 and formed a task force the next day. Council chairman Professor Raymond Liang Hin-suen said a police report had been filed through the Department of Health.

The clinic apologised to the affected clients on Tuesday night. It stated that it had created an internal task force to review procedures and improve operations.

Articoli correlati

Hong Kong paediatrician given nine-month ban over 2009 misconduct case

A Hong Kong paediatrician has been removed from the General Register for nine months after a Medical Council panel found him guilty of professional misconduct in a 2009 case that left a newborn with lifelong disabilities.

China sends human embryo models into space for study

19 maggio 2026 Riportato dall'IA

On May 11, the Tianzhou 10 cargo spacecraft successfully launched, carrying human embryo models into space. This marks the world's first in situ experiment exploring how microgravity and cosmic radiation affect early human development.

Africa

SHA suspends MP Shah Hospital for 90 days over complaints

Asia

Gurugram couple says DNA test showed IVF twins not biologically theirs

Asia

Hong Kong poultry stall suspended for disinfection after bird flu trace

Hong Kong Law Society closes firm linked to crash-for-cash scams

Hong Kong's Law Society has ordered the immediate closure of Raymond Lam & Associates, a firm under investigation for its alleged role in crash-for-cash scams. The council appointed Robertsons as the intervention agent to protect clients and the public, citing prima facie evidence of dishonest acts and accounting violations by employees.

Two gene-editing baby startups shut down after less than a year

24 aprile 2026 Riportato dall'IA

Bootstrap Bio and Manhattan Genomics, biotech firms launched last year to pursue human embryo editing for preventing serious diseases, have closed their doors. The companies cited financial difficulties and internal conflicts as reasons for the shutdowns. The developments highlight challenges in the controversial field of gene-edited babies.

Asia